BioDelivery Sciences International, Inc. (Nasdaq: BDSI) reached up 120.24% in morning trading to $1.85 with 2M shares traded. BioDelivery Sciences International is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics. BDSI is focusing on developing products to meet unmet patient needs in the areas of pain management and oncology supportive care. BioDelivery Sciences International, Inc. (Nasdaq: BDSI) today announced the signing of a worldwide license and development agreement with Endo Pharmaceuticals (Nasdaq: ENDP) for the exclusive rights to develop and commercialize BEMA Buprenorphine for the treatment of chronic pain. BEMA Buprenorphine utilizes BDSI's patented and proven BioErodible MucoAdhesive (BEMA) technology to deliver the opioid analgesic buprenorphine.
The Tirex Corporation (OTCBB/PK: TXMC) reached up 86.67% in morning trading to $.0028 with 33M shares traded. Tirex's TCS (Tirex Cryo System) process freezes scrap tire pieces with cold air – as opposed to expensive liquid nitrogen – and then "fractures" the rubber into granules in a patented "fracturing mill," instead of cutting and shredding it. This process also separates the marketable strands of steel and fiber from the frozen ground rubber as an environmentally friendly, economically attractive "green" tire recycling system. The Tirex Corporation (OTCBB/PK: TXMC) announced today that it entered into a Joint Venture Agreement with Wyoming Corporate Headquarters LLC (WCH) of West Columbia, SC , to recycle scrap tires.
Tengion, Inc. (NASDAQ: TNGN) reached up 10.52% in morning trading to $.64 with 400K shares traded. Tengion, a clinical-stage biotechnology company, has pioneered the Organ Regeneration Platform™ that enables the Company to create proprietary product candidates that are intended to harness the intrinsic regenerative pathways of the body to produce a range of native-like organs and tissues. Tengion's product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. Tengion, Inc. (NASDAQ: TNGN) yesterday announced it has completed the relocation of its corporate headquarters from East Norriton, Pennsylvania to the Company's existing facility in Winston-Salem , North Carolina.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com:
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
